In contrast, a small molecule that is BBB-permeable, has good pharmacokinetic properties and can act as an NGF-mimetic is a good candidate to counteract the harmful Aβ-induced phenotype presented in AD, with important therapeutic potential [90,91]. The gene discussed is NGF; the disease is Alzheimer disease.